Antihypertensive effects of a fixed-dose combination of losartan and hydrochlorothiazide plus amlodipine versus a hydrochlorothiazide and atenolol combination plus amlodipine in subjects with ambulatory systolic hypertension
Phase of Trial: Phase IV
Latest Information Update: 19 Apr 2017
At a glance
- Drugs Losartan/hydrochlorothiazide (Primary) ; Amlodipine; Atenolol; Hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- 27 Feb 2009 Additional trial centre Merck reported by ClinicalTrials.gov, last updated 27 Feb 2009.
- 27 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Nov 2005 New trial record.